This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Shinsuke Taki: Innovator in Polypeptide Technology
Introduction
Shinsuke Taki is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications. His work focuses on innovations that can improve medical treatments and patient outcomes.
Latest Patents
Shinsuke Taki holds a patent for polypeptides capable of binding to heavy chains of IL-2 receptors. This invention relates to polypeptides that can inhibit the binding between IL-2 and the beta chain of the IL-2 receptor. The polypeptides produced through this invention are particularly useful in preventing organ transplant rejection and treating autoimmune diseases. His patent represents a significant advancement in the field of immunology.
Career Highlights
Taki is associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work at Ajinomoto has allowed him to explore innovative solutions that address critical health challenges. With a focus on research and development, he has contributed to the advancement of biopharmaceuticals.
Collaborations
Shinsuke Taki has collaborated with notable colleagues, including Junji Hamuro and Toshiro Shimamura. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Shinsuke Taki's contributions to biotechnology, particularly through his patent on polypeptides, highlight his role as an innovator in the medical field. His work continues to pave the way for new treatments and therapies that can improve patient care and outcomes.